Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view

Issues: In an effort to increase the number of people undergoing hepatitis C treatment, a range of initiatives are planned or underway to provide treatment in non-specialist services, such as opioid pharmacotherapy treatment (OPT) clinics. Approach: This commentary considers the implications of this...

Full description

Bibliographic Details
Main Authors: Treloar, C., Fraser, Suzanne
Format: Journal Article
Published: Wiley-Blackwell Publishing Ltd. 2009
Online Access:http://hdl.handle.net/20.500.11937/12439
_version_ 1848748076555042816
author Treloar, C.
Fraser, Suzanne
author_facet Treloar, C.
Fraser, Suzanne
author_sort Treloar, C.
building Curtin Institutional Repository
collection Online Access
description Issues: In an effort to increase the number of people undergoing hepatitis C treatment, a range of initiatives are planned or underway to provide treatment in non-specialist services, such as opioid pharmacotherapy treatment (OPT) clinics. Approach: This commentary considers the implications of this new approach to treatment delivery, taking account of individual-level issues generally discussed in the literature, such as knowledge of treatment and concerns about side effects. In addition, because less visible organisational and structural factors would equally influence the successful implementation of hepatitis C treatment in OPT services, these are also explored. Key Findings: Provision of hepatitis C treatment in OPT services raises a broad range of pressing questions, from individual knowledge and concern about treatment, to workforce issues, such as discrimination, and tensions between the need for supportive care during hepatitis C treatment and the surveillant, regulatory nature of OPT clinic operations. Implications: A thorough critical examination of the structure and delivery of all services involved is necessary. Social research can play a unique role in this assessment because of its ability to generate detailed insights into lived experience and make use of social theories that allow previously invisible operations of power to become visible. Conclusion: The success of hepatitis C treatment in new sectors,such as OPT clinics, is not a given. Close attention needs to be paid to the context and culture in which OPT is delivered. In turn, this needs to be considered alongside the context and culture necessary for successful hepatitis C treatment delivery.
first_indexed 2025-11-14T06:59:18Z
format Journal Article
id curtin-20.500.11937-12439
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:59:18Z
publishDate 2009
publisher Wiley-Blackwell Publishing Ltd.
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-124392017-02-28T01:33:49Z Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view Treloar, C. Fraser, Suzanne Issues: In an effort to increase the number of people undergoing hepatitis C treatment, a range of initiatives are planned or underway to provide treatment in non-specialist services, such as opioid pharmacotherapy treatment (OPT) clinics. Approach: This commentary considers the implications of this new approach to treatment delivery, taking account of individual-level issues generally discussed in the literature, such as knowledge of treatment and concerns about side effects. In addition, because less visible organisational and structural factors would equally influence the successful implementation of hepatitis C treatment in OPT services, these are also explored. Key Findings: Provision of hepatitis C treatment in OPT services raises a broad range of pressing questions, from individual knowledge and concern about treatment, to workforce issues, such as discrimination, and tensions between the need for supportive care during hepatitis C treatment and the surveillant, regulatory nature of OPT clinic operations. Implications: A thorough critical examination of the structure and delivery of all services involved is necessary. Social research can play a unique role in this assessment because of its ability to generate detailed insights into lived experience and make use of social theories that allow previously invisible operations of power to become visible. Conclusion: The success of hepatitis C treatment in new sectors,such as OPT clinics, is not a given. Close attention needs to be paid to the context and culture in which OPT is delivered. In turn, this needs to be considered alongside the context and culture necessary for successful hepatitis C treatment delivery. 2009 Journal Article http://hdl.handle.net/20.500.11937/12439 Wiley-Blackwell Publishing Ltd. restricted
spellingShingle Treloar, C.
Fraser, Suzanne
Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view
title Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view
title_full Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view
title_fullStr Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view
title_full_unstemmed Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view
title_short Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view
title_sort hepatitis c treatment in pharmacotherapy services: increasing treatment uptake needs a critical view
url http://hdl.handle.net/20.500.11937/12439